Showing results (1071-1080 of 1,173) with videos related to
Sort By:
Pageof 118
Journal of the American College of Cardiology|January 15, 2016
Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter StudyAdmir Dedic, Marisa M Lubbers, Jeroen Schaap, et al.Virology|November 28, 2006
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivoStefan Pöhlmann, Jan Münch, Sheriff Aziz, et al.Immunology and Cell Biology|May 24, 2018
CD57 identifies T cells with functional senescence before terminal differentiation and relative telomere shortening in patients with activated PI3 kinase delta syndromePaola Cura Daball, Monica Sofia Ventura Ferreira, Sandra Ammann, et al.Circulation|February 4, 2009
Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 casesJochem W van Werkum, Antonius A C M Heestermans, Fleur I de Korte, et al.The Plant Cell|March 21, 2024
The dimorphic diaspore model Aethionema arabicum (Brassicaceae): Distinct molecular and morphological control of responses to parental and germination temperaturesJake O Chandler, Per K I Wilhelmsson, Noe Fernandez-Pozo, et al.The Plant Journal : for Cell and Molecular Biology|November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patensNoe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.The Journal of Allergy and Clinical Immunology|January 9, 2023
Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutationsMaria Elena Maccari, Pascal Schneider, Cristian Roberto Smulski, et al.Hypertension (Dallas, Tex. : 1979)|October 25, 2017
Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN TrialMelvin D Lobo, Christian Ott, Paul A Sobotka, et al.Atherosclerosis|July 19, 2011
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patientsWijnand K den Dekker, Jaco H Houtgraaf, Yoshinobu Onuma, et al.Iscience|November 29, 2023
Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIV<sub>mac239</sub> in rhesus macaquesAlexandre Laliberté, Caterina Prelli Bozzo, Christiane Stahl-Hennig, et al.Pageof 118